Jump to content

A precision-instrument readout of the PT-141 (bremelanotide) literature — the approved-population evidence, the effect-size debate, and the tolerability picture read first.

PT-141 source questions and corrections

Contact the PT-141 Editors

Write about an error or a study's source. This inbox answers no health questions and won't help you get the drug.

Write About a Source or Possible Error

You can use the form to reach the Medicine PT-141 editors. Tell us which PT-141 page and claim you mean. If you found a changed study, send the source. Your clear note may help us correct a fact.

Think of this inbox like a newspaper correction desk. The editors check words and sources. They don't look at your health or give medical advice. They also don't sell or supply any drug.

Bremelanotide is a prescription drug with one approved use. Your own doctor decides whether it fits you. Nobody else can make that choice with you. We also won't answer your requests about buying, finding, or pricing the drug.

You May Get a Reply After We Check the Source

This inbox handles PT-141 writing and source questions. Point us to the page and number you saw. We will compare it with the listed source. Your note may lead to a correction.

Please tell us if you saw a changed or withdrawn paper. The same goes for a new warning added by a journal. We'd rather fix an error than defend it. We read every note, though we can't reply to each one.

The form doesn't open an account or start a visit. It can't place an order. No doctor will review your case through it. The only purpose is to improve what the site says.